
|Articles|July 1, 2002
Topical shows persistence
Los Angeles - Preliminary results from a split-face, double-blind study are further substantiating the efficacy of a unique topical product containing growth factors and antioxidants for improving photodamaged skin and indicate that its effects persist and increase even after treatment is stopped, Richard E. Fitzpatrick, M.D., reported at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















